DNB ASSET MANAGEMENT AS Regeneron Pharmaceuticals, Inc. Transaction History

DNB ASSET MANAGEMENT AS portfolio value:

$14.28M
portfolio value

DNB ASSET MANAGEMENT AS quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -32.83% -10.14K shares -3.96M $688.87 20.74K
Q2 2022 share Decrease -5.12% -1.66K shares -4.47M $591.13 30.88K
Q1 2022 share Decrease -3.76% -1.27K shares 1.37M $698.42 32.54K
Q4 2021 share Decrease -15.97% -6.42K shares -2.99M $642.51 33.81K
Q3 2021 share Decrease -14.89% -7.04K shares -2.05M $605.18 40.24K
Q2 2021 share Increase +12.34% 5.19K shares 6.49M $558.54 47.29K
Q1 2021 share Increase +13.45% 4.99K shares 1.99M $473.14 42.09K
Q4 2020 share Increase +2.19% 795 shares -2.39M $483.11 37.10K
Q3 2020 share Decrease -53.21% -41.28K shares -28.06M $559.78 36.30K
Q2 2020 share Increase +16.95% 11.24K shares 15.99M $623.65 77.59K
Q1 2020 share Increase +7.17% 4.43K shares 9.15M $488.29 66.34K
Q4 2019 share Increase +22.42% 11.33K shares 9.21M $375.48 61.90K
Q3 2019 share Increase +58.93% 18.75K shares 4.06M $277.4 50.57K
Q2 2019 share Decrease -35.59% -17.58K shares -10.32M $313 31.81K
Q1 2019 share Decrease -7.66% -4.09K shares 302.71K $410.62 49.39K
Q4 2018 share Increase +136.40% 30.86K shares 10.83M $373.5 53.49K
Q3 2018 share Increase 0.00% 22.63K shares 9.14M $404.04 22.63K
Q2 2018 share Decrease -100.00% -26.4K shares -9.09M $344.99 0
Q1 2018 share Increase +8.64% 2.1K shares -44.72K $344.36 26.4K
Q4 2017 share Increase 0.00% 24.3K shares 9.13M $375.96 24.3K